Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Exploring Patient, Caregiver, and Prescriber Preferences for an Injectable Antipsychotic Administered Every 2 Months for the Maintenance Treatment of Schizophrenia: A Multicenter Qualitative Interview Study Conducted in Europe

Patient Prefer Adherence. 2025 Apr 29;19:1179-1195. doi: 10.2147/PPA.S520160. eCollection 2025.ABSTRACTPURPOSE: This qualitative study explored patient, caregiver, and prescriber preferences for long-acting injectable (LAI) dosing frequency,...
close chatgpt icon
ChatGPT

Enter your request.

Psychiatry AI: Real-Time AI Scoping Review (RAISR4D)